Trial Profile
Phase1 trial of Panitumumab combined with S-1 and irrinotecan in advanced/metastatic colorectal cancer
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Panitumumab (Primary) ; Irinotecan
- Indications Colorectal cancer
- Focus Adverse reactions
- 18 May 2016 New trial record